G E Gondolesi
Affiliation: Mount Sinai School of Medicine
- Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteriaGabriel E Gondolesi
Recanati Miller Transplantation Institutes, The Mount Sinai Hospital, New York, NY 10029, USA
Ann Surg 239:142-9. 2004..LDLT allows timely transplantation in patients with early or with large HCC...
- Biliary complications in 96 consecutive right lobe living donor transplant recipientsGabriel E Gondolesi
Recanati Miller Transplantation Institute, Mount Sinai Hospital, Box 1104, One Gustave L Levy Place, New York, NY 10029, USA
Transplantation 77:1842-8. 2004..Biliary reconstruction represents one of the most challenging parts of right lobe (RL) living donor liver transplantations (LDLTs). Different causes, surgical techniques, and treatments have been suggested but are incompletely defined...
- Reduction of ischemia-reperfusion injury in parenchymal and nonparenchymal liver cells by donor treatment with DL-alpha-tocopherol prior to organ harvestG E Gondolesi
Laboratorio de Trasplante de Organos, Catedra de Cirugia B, Buenos Aires, Argentina
Transplant Proc 34:1086-91. 2002
- Venous hemodynamics in living donor right lobe liver transplantationGabriel E Gondolesi
The Recanati Miller Transplantation Institute, Mount Sinai School of Medicine, New York, NY 10029, USA
Liver Transpl 8:809-13. 2002..Evaluation of hepatic and portal venous flow is a relatively easy skill to acquire. Intraoperative ultrasound may enable the surgeon to predict graft dysfunction and possibly, may be used to implement pre-emptive therapies...
- One hundred nine living donor liver transplants in adults and children: a single-center experienceC M Miller
Recanati Miller Transplantation Institute, Mount Sinai Hospital, Mount Sinai School of Medicine, New York, New York 10029, USA
Ann Surg 234:301-11; discussion 311-2. 2001..To summarize the evolution of a living donor liver transplant program and the authors' experience with 109 cases...
- Accurate method for clinical assessment of right lobe liver weight in adult living-related liver transplantG E Gondolesi
Recanati Miller Transplantation Institute, New York, NY, USA
Transplant Proc 36:1429-33. 2004..Computed tomography (CT) and magnetic resonance imaging (MRI) are the current best standards. We applied a new formula to estimate right liver lobe weight in living donors and compared our results with CT and MRI...
- Effect of ischemia-reperfusion on the incidence of acute cellular rejection and timing of histologic hepatitis C virus recurrence after liver transplantationM T Killackey
Recanati Miller Transplantation Institute, The Mount Sinai Medical Center, New York, USA
Transplant Proc 40:1504-10. 2008....
- Noninvasive preoperative evaluation of biliary anatomy in right-lobe living donors with mangafodipir trisodium-enhanced MR cholangiographyJ Goldman
Department of Radiology, Mount Sinai Hospital, New York, New York 10029, USA
Transplant Proc 35:1421-2. 2003..Volumetric magnetic resonance cholangiography (MRCP) using Mangafodipir trisodium (Mn-DPDP) contrast has been recently proposed to evaluate the biliary anatomy of living donor candidates...
- Leukemia after liver transplantC A Doti
Department of Medicine, Mount Sinai Medical Center, One Gustave L. Levy Place, New York, NY 10029, USA
Transplantation 72:1643-6. 2001..The latency period to diagnosis after transplant was 10-19 months. CONCLUSIONS: Acute leukemia, although rare after liver transplantation, should be considered in the differential diagnosis of hematological complications...
- Neo-suprahepatic cava: a case report of a modified technique for domino liver transplantationJ M Padín
Multi Organ Transplant Institute, University Hospital, Favaloro Foundation, Capital Federal, Buenos Aires, Argentina
Transplant Proc 43:2090-2. 2011....
- Analysis of immune cells draining from the abdominal cavity as a novel tool to study intestinal transplant immunobiologyD Meier
Laboratorio de Investigaciones del Sistema Inmune LISIN FCE Universidad Nacional de La Plata, La Plata, Buenos Aires, Argentina
Clin Exp Immunol 162:138-45. 2010..Therefore, this analysis may provide information useful for understanding ITx immunobiology and eventually could also be of interest for clinical management...
- A simple new formula to assess liver weightT Yoshizumi
Recanati/Miller Transplantation Institute, Mount Sinai School of Medicine, New York, NY 10029, USA
Transplant Proc 35:1415-20. 2003..CONCLUSIONS: A simple formula to calculate liver weight in donors with BSA >1.0 is: LW = 772 x BSA, and for donors with BSA </=1.0: Liver Weight = 772 x BSA - 38...
- Strongyloides hyperinfection syndrome after intestinal transplantationG Patel
Division of Infectious Diseases, Mount Sinai School of Medicine, New York, New York 10029, USA
Transpl Infect Dis 10:137-41. 2008..We also review the current literature and address both prophylaxis and treatment of strongyloidiasis in the solid organ transplant patient...
- Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosisSasan Roayaie
Recanati Miller Transplantation Institute, Department of Medicine, Mount Sinai Medical Center, Mount Sinai NYU Health System, New York, NY 10029, USA
Liver Transpl 10:534-40. 2004..Nonetheless, some patients with recurrence can be expected to live for a considerable period of time. Recurrent disease should be treated surgically when possible, because surgery is independently associated with longer survival...
- Anatomic variations in right liver living donorsGiovanni Varotti
Recanati/Miller Transplantation Institute, Mount Sinai Hospital, One Gustave L. Levy Place, New York, NY 10029, USA
J Am Coll Surg 198:577-82. 2004..The incidence of S6 or S7 short hepatic vein was 38%. CONCLUSIONS: Anatomic variations are common but do not contraindicate donation; surgeons should be prepared to recognize and manage them...
- Combined adult-to-adult living donor right lobe liver transplantation and pancreatoduodenectomy for distal bile duct adenocarcinoma in a patient with primary sclerosing cholangitisGiovanni Varotti
Recanati/Miller Transplantation Institute, The Mount Sinai Hospital, New York, NY, USA
J Am Coll Surg 197:765-9. 2003..CONCLUSIONS: Combined living-donor liver transplantation and pancreatoduodenectomy is feasible and allows timely and elective surgical control of carefully selected distal bile duct tumors in the setting of end-stage liver disease...
- End-to-end portocaval shunt for venous drainage of the native foregut in combined liver-intestinal transplantationGabriel E Gondolesi
Recanati Miller Transplantation Institute, Mount Sinai School of Medicine, New York, NY 10029 6547, USA
Pediatr Transplant 10:98-100. 2006..This is the first description of this technique that is relatively simple to perform, creating a large vascular conduit with high flow rates and theoretically less turbulence compared with the end-to-side shunt...
- Early and frequent histological recurrence of Crohn's disease in small intestinal allograftsNoam Harpaz
Department of Pathology, The Mount Sinai Medical Center, New York, NY 10029, USA
Transplantation 80:1667-70. 2005..However, systematic studies to determine the frequency, predictors, and clinical implications of recurrent Crohn's disease have not been reported..
- Marked Differences in acute cellular rejection rates between living-donor and deceased-donor liver transplant recipientsLawrence U Liu
Recanati/Miller Transplantation Institute, The Mount Sinai Medical Center, New York, NY 10029, USA
Transplantation 80:1072-80. 2005..CONCLUSIONS.: Rates of ACR and high-degree ACR are decreased in living-related liver transplant recipients. This difference is likely genetically related as ACR rates are lower in recipient-donor pairs of increasing genetic similarity...
- Liver-intestine transplant from a pediatric donor with unrecognized mitochondrial succinate cytochrome C reductase deficiencyAaron R Zucker
Division of Pediatric Critical Care, Connecticut Children s Medical Center, Hartford, CT, USA
Transplantation 79:356-8. 2005....
- Adenovirus infection in pediatric small bowel transplantation recipientsRebecca J Pinchoff
Department of Pediatrics, Mount Sinai School of Medicine, New York, NY 10029, USA
Transplantation 76:183-9. 2003..01). CONCLUSIONS: Adenovirus was commonly isolated from children undergoing intestinal transplantation. Progression to disease may be associated with more intensive immunosuppressive therapy and inability to clear virus...
- Isolated intestinal transplantation: proof of clinical efficacyThomas M Fishbein
Georgetown University Hospital, Washington, DC 20007, USA
Transplantation 76:636-40. 2003..If high survival could be achieved and if parenteral nutrition-associated liver disease were reversible, this procedure could be more widely applied, with early liver dysfunction indicating the need for transplant evaluation...
- Post-liver transplant acute renal failure: factors predicting development of end-stage renal diseaseAnil S Paramesh
The Recanat/Miller Transplantation Institute, The Mount Sinai School of Medicine, New York, NY 10029-6574, USA
Clin Transplant 18:94-9. 2004..ESRD patients who received kidney transplantation had higher 10-yr survival rates when compared with patients maintained on dialysis...
- Medication adherence in pediatric and adolescent liver transplant recipientsEyal Shemesh
Department of Pediatrics, Mount Sinai Medical Center, New York, New York 10029, USA
Pediatrics 113:825-32. 2004..There are also no published data about the age of transition at which a child assumes responsibility over taking the medications. This information is important if interventions to improve adherence are contemplated...